CD8A and plasma cell myeloma: Moreover, regarding the immunological mechanism of action, counts of CD3+ and CD3+CD8+ T cells, which contribute an immune response for myeloma cells [24,25], were significantly increased with POM even after LEN resistance occurred while POM did not change CD4+ T cell level significantly [26].